Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule belonging to the n-benzylbenzamide class, with the molecular formula C16H12BrClFNO4 and a molecular weight of approximately 416.6 g/mol. It is an experimental compound, not approved for clinical use, and is referenced in chemical databases such as DrugBank (DB07028), PubChem (CID 16058629), and ChemSpider. There is no publicly available information on its mechanism of action, biological targets, or therapeutic indications[1][3][5]. No evidence suggests it has reached clinical development or been assigned to a specific pharmaceutical developer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (2-{[(4-bromo-2-fluorobenzyl)amino]carbonyl}-5-chlorophenoxy)acetic acid.